Knowledge Ecology International

On Monday, 22 September 2014, Bangladesh delivered the following statement on behalf of the Asia Pacific Group. Here below is the Group’s position on WIPO’s normative work including copyright limitations and exceptions for libraries and archives, copyright limitations and exceptions for educational and research institutions and persons with other disabilities, the proposed Design Law Treaty, the proposed broadcasting treaty and proposed instruments for the protection of genetic resources, traditional knowledge and traditional cultural expressions.

Continue Reading →

(More on Colombia here: /colombia)
Continue Reading →

A long standing parlor game for WIPO insiders and observers during the summer of 2014 involved guessing the composition of WIPO’s new Senior Management Team (the team of deputy director generals and assistant director generals who form WIPO’s cabinet). On 16 September 2014, the WIPO secretariat laid this to rest by revealing the composition of the new WIPO Senior Management Team of deputy director generals and assistant director generals. New faces in the cabinet include: Mr. Continue Reading →

On Monday, September 15, 2014, Gilead announced licensing agreements with 7 generic drug manufacturers, for two of its HCV drugs, including sofosbuvir, which is currently the most important HCV drug, and the basis for Gilead’s value to shareholders. KEI’s statement from Monday, and links to other NGO comments are here: https://www.keionline.org/node/2082.

Continue Reading →

Today Gilead announced it will provide seven generic drug manufacturers licenses to make and sell two drugs that are used in combination to treat the Hepatitis C Virus (HCV) in 91 developing countries.

Continue Reading →

In the piece, WIPO General Assembly 2014: Hard Decisions on the Design Law Treaty and Treaty for Protection of Genetic Resources (22 July 2014), KEI highlighted the hard decisions awaiting the WIPO General Assembly (22 September 2014 to 30 September 2014) with respect to the Design Law Treaty, the imminent revision of the Lisbon Agreement to include geographical indications and WIPO’s work to conclude an instrument for the protection of genetic resources, traditional knowledge and folklore. Continue Reading →

In a concerted bid to contain the emerging threat posed by antibiotic resistance, in May 2014, the World Health Organization’s (WHO) 67th World Health Assembly (WHA) passed WHA resolution 67.25 on “Antimicrobial resistance” instructing the WHO to “develop a global action plan to combat antimicrobial resistance” by May 2015 (Source: WHO page on Draft Global action plan on antimicrobial resistance). Continue Reading →

In May 2014, the World Health Organization’s (WHO) 67th World Health Assembly (WHA67) passed decision WHA67(15) setting the stage for the creation of a new pooled funding mechanism for R&D. Continue Reading →

Following litigation by several lobbyists, OMB is revising its guidance on the appointment of lobbyists to federal advisory committees, boards, and commissions. Now, lobbyists can serve on these committees, including the USTR advisory boards. Money quote:

Continue Reading →